"Are they going to go to the FDA with this or just EMA? "
They have a SPA, so they are clearly submitting a BLA to the FDA. Timeframe is first half of '11.
It is the EMEA that is unclear.
There is also an open question of what happens if the ALCL trial comes in strongly positive. They could try and add that to indication in the same submission.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.